The Case for Donating US Covid Vaccines Overseas
For now, there’s not enough vaccine for the U.S., but that could change within a few months. Vaccinating other nations will be key to stopping the pandemic – and keeping it away from our shores.
Vaccines
561 - 580 of 812 Results
-
-
KHN’s ‘What the Health?’: ACA Packs More Benefits — And More Confusion
The covid relief bill signed by President Joe Biden includes a long list of new health benefits for consumers. But many eligible people may have difficulty taking advantage of them because of the interaction with the income tax system and a lack of expert guidance. Meanwhile, Democrats are debating internally about what should come next on the health agenda. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Rachana Pradhan of KHN join KHN’s Julie Rovner to discuss these issues and more.
-
POSTCARD FROM LONG BEACH
‘Super-Sized’ Vaccine Clinic Offers Food Workers Some Relief
Long Beach, which has its own health department, kicked off a vaccination campaign for essential workers by inviting 3,000 food workers to a splashy vaccination event at the city’s convention center.
By Lori Basheda -
Landmark Covid Relief Law Pumps More Than $100 Billion Into Public Health
The law provides money to enhance coronavirus testing and contact tracing, support federal efforts on vaccine distribution and hire more public health workers. But advocates worry support will wane when the pandemic is over.
-
Can Vaccination and Infection Rates Add Up to Reach Covid Herd Immunity?
A financial research firm offered its take on when states might be reaching the sought-after status of herd immunity. But some experts say the analysis is oversimplified.
-
Covid Cases Plummet 83% Among Nursing Home Staffers Despite Vaccine Hesitancy
Federal records show a steep decline in staff covid cases since December, when health care workers at thousands of nursing homes began getting their shots. Still, many are reluctant to get vaccinated.
By Melissa Bailey and Shoshana Dubnow -
Journalists Explore Covid Relief Bill and Vaccine Issues
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
-
‘Explained by KHN’: Consumer Concerns About the Covid Vaccines
Our newsroom has some of the best and smartest health care and health policy reporters in the business. We’ve created a new video series — “Explained by KHN” — in which our correspondents and editors answer common health care and policy questions. In this edition we cover consumer concerns over the covid-19 vaccines.
-
To Extract More Doses per Vial, Vaccinators Put Squeeze on FDA to Relax Vaccine Handling Advice
Although vaccine supply is ramping up, the supply gap puts pressure on vaccinating teams to extract every drop they can. Some are asking the FDA to waive guidance against extracting vaccine from two vials with the same needle. It’s worth a shot.
By Arthur Allen -
KHN’s ‘What the Health?’: Expanding the ACA in an Unpredicted Way
Beyond the billions of dollars aimed squarely at the pandemic, the covid relief bill cleared by Congress this week includes significant changes to health policy. Among them are the first major expansions to the Affordable Care Act since its enactment 11 years ago and changes that could expand coverage for the Medicaid program. Tami Luhby of CNN, Alice Miranda Ollstein of Politico and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
-
Meet the Retired Nurse Who Could Give Covid Shots But Couldn’t Get One
She followed up on every possible avenue that would allow her to register for a vaccination appointment. Ultimately, it took a 40-minute drive and someone else’s cancellation to make it happen.
-
Vaccine Altruists Find Appointments for Those Who Can’t
An army of volunteers help people who otherwise would have had difficulty securing a covid vaccination because of cumbersome computer or telephone registration systems.
-
High Obesity Rates in Southern States Magnify Covid Threat
In the American South — home to nine of the nation’s 12 heaviest states — obesity is playing a role not only in covid outcomes, but in the calculus of the vaccination rollout.
By Sarah Varney -
Pfizer’s Newest Vaccine Plant Has Persistent Mold Issues, History of Recalls
After nearly a decade’s worth of federal inspections, reprimands and corrective action plans, has Pfizer fixed the facility that will be filling vials of its covid vaccine?
-
What Childhood Vaccine Rates Can, and Can’t, Teach Us About Covid Vaccines
Hesitancy toward routine childhood vaccines doesn’t necessarily predict hesitancy toward a covid shot.
-
In Alabama, South Carolina and Louisiana, CVS Vaccine Appointments Go Unfilled
Dozens of open appointment slots in the three Southern states last week stood in sharp contrast to states such as Delaware, Connecticut and Pennsylvania, where spots generally were claimed by midmorning or earlier.
-
Ouch! Needle-Phobic People Scarred by So Many Images of Covid Shots
The pictures are on the nightly news, on billboards, bus stop posters and all over social media. How can people who fear needles manage to get their covid shots?
-
Behind The Byline: Reporting Road Trip
Check out KHN’s video series — Behind The Byline: How the Story Got Made. Come along as journalists and producers offer an insider’s view of health care coverage that does not quit.
-
On Vacci-Dating: Singles Seem Enamored of Sharing Vaccination Status Online. Is That Wise?
When considering whether to meet up with someone who is vaccinated versus unvaccinated, vaccinated sounds somewhat safer. But before you give pandemic dating a shot, heed these warnings from experts.
-
Biden’s Criticism of Trump Team’s Vaccine Contracts Is a Stretch
Under the Trump administration, the U.S. had agreed to buy at least 1 billion doses of covid vaccine, enough to vaccinate 550 million people. Those agreements, though, applied to vaccines that were authorized as well as those still in development. And the Biden team had the advantage of 20/20, experts say.